The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.

The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma. The U.S. Food and Drug Administration (FDA) has ...

The US Food and Drug Administration (FDA) will soon decide on whether to expand the label of MSD’s Welireg (belzutifan) to ...

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025. The FDA granted priority review to a supplemental new ...

One way or another, beta blockers are always in the news. Take, for instance, Los Angeles Chargers Head Coach Jim Harbaugh, who revealed in October that he's part of a growing group of Americans ...

PURPOSE: Alpha blocker therapy has been successfully used to decrease residual urine in children with complex neuropathic and nonneuropathic voiding dysfunction. We evaluated the safety and ...

In an NIH-sponsored trial, researchers examined whether an α-adrenergic-receptor blocker — a drug commonly prescribed for symptoms of benign prostatic hyperplasia — alleviates symptoms of ...

Health Minister Mark Butler said that interim advice on the use of one part of that treatment, puberty blockers, will be completed in the middle of next year. That treatment was banned last year ...

The Albanese government has launched a review into the treatment of transgender children and adolescents, which will develop new national guidelines for puberty blockers and hormone treatments ...

Amazon.com, Inc. engages in the retail sale of consumer products, advertising, and subscriptions service through online and physical stores in North America and internationally. The company ...

Some beta-blockers also bind to sites called alpha receptors. These receptor sites are found in the heart and other areas of your body. They are responsible for many functions, like regulating ...